|
BY07118 |
2-naphthalen-1-yl-N-[4-(trifluoromethyl)phenyl]acetamide |
666209-67-2 |
C19H14F3NO |
329.3158 |
VIEW DETAILS > |
|
BZ10600 |
2-[(4Z)-4-[(2,5-dimethoxy-4-pyrrolidin-1-ylphenyl)methylidene]-2,5-dioxoimidazolidin-1-yl]-N-phenylacetamide |
666209-69-4 |
C24H26N4O5 |
450.4870 |
VIEW DETAILS > |
|
BS14965 |
2-bromo-N-[2-[(2-bromophenyl)methylsulfanyl]-1,3-benzothiazol-6-yl]benzamide |
666209-70-7 |
C21H14Br2N2OS2 |
534.2867 |
VIEW DETAILS > |
|
BV13741 |
3-(2-((1Z)-(4-oxo-2-(o-tolylimino)thiazolidin-5-ylidene)methyl)-1H-pyrrol-1-yl)benzoic acid |
666209-71-8 |
C22H17N3O3S |
403.4537 |
VIEW DETAILS > |
|
BX44702 |
2-bromo-N-[2-[(3-methylphenyl)methylsulfanyl]-1,3-benzothiazol-6-yl]benzamide |
666209-72-9 |
C22H17BrN2OS2 |
469.4172 |
VIEW DETAILS > |
|
BU04074 |
3-[2-[(E)-[1-(4-chlorophenyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene]methyl]pyrrol-1-yl]benzoic acid |
666209-73-0 |
C22H14ClN3O4S |
451.8823 |
VIEW DETAILS > |
|
BX63827 |
N-[2-[(3-acetyl-2,4,6-trimethylphenyl)methylsulfanyl]-1,3-benzothiazol-6-yl]-2-bromobenzamide |
666209-74-1 |
C26H23BrN2O2S2 |
539.5070 |
VIEW DETAILS > |
|
BW05129 |
N-(2,4-dimethylphenyl)-2-[(5Z)-5-[(1-methylpyrrol-2-yl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]acetamide |
666209-75-2 |
C19H19N3O3S |
369.4375 |
VIEW DETAILS > |
|
BU49845 |
(5Z)-5-[(2,5-dimethoxy-4-pyrrolidin-1-ylphenyl)methylidene]-3-(3-methoxypropyl)-2-phenylimino-1,3-thiazolidin-4-one |
666209-77-4 |
C26H31N3O4S |
481.6070 |
VIEW DETAILS > |
|
BT56954 |
2-bromo-N-[2-(2-naphthalen-2-yl-2-oxoethyl)sulfanyl-1,3-benzothiazol-6-yl]benzamide |
666209-79-6 |
C26H17BrN2O2S2 |
533.4594 |
VIEW DETAILS > |